We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Probes Acquires Interfacial Dynamics

By HospiMedica staff writers
Posted on 30 Apr 2003
In a move to expand its bead-based assay systems, Molecular Probes, Inc. (Eugene, OR, USA) has acquired Interfacial Dynamics Corp. (IDC, Portland, OR, USA). Financial terms were not disclosed.

IDC will become a wholly owned subsidiary of Molecular Probes. IDC was a pioneer in the production of surfactant-free, high-quality, reproducible latex microspheres. The acquisition gives Molecular Probes the ability to design and manufacture these latex microspheres for its own products and to offer a full line of microspheres to customers. Molecular Probes is a leading global provider of fluorescence-based detection assays.

"Adding IDC's outstanding capabilities in microsphere development and manufacturing to our expertise in fluorescence and conjugation, along with our relationships with major reagent, diagnostic, and instrument companies, gives us numerous opportunities to develop new bead-based assays and particle-based detection systems for a wide variety of uses,” said Anthony Martin, Ph.D., president and CEO of Molecular Probes.





Related Links:
Molecular Probes
Interfacial Dynamics

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests